JPMorgan Chase & Co. Issues Positive Forecast for UnitedHealth Group (NYSE:UNH) Stock Price

UnitedHealth Group (NYSE:UNH) had its price objective lifted by equities research analysts at JPMorgan Chase & Co. from $389.00 to $420.00 in a report released on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the healthcare conglomerate’s stock. JPMorgan Chase & Co.‘s target price points to a potential upside of 14.22% from the company’s previous close.

UNH has been the subject of several other research reports. Argus raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 price target for the company in a research report on Wednesday, April 22nd. Raymond James Financial upgraded shares of UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 price target on the stock in a report on Wednesday, April 1st. Wells Fargo & Company increased their price target on shares of UnitedHealth Group from $370.00 to $397.00 and gave the company an “overweight” rating in a report on Wednesday, April 22nd. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price target for the company in a research note on Tuesday, April 7th. Finally, Weiss Ratings downgraded shares of UnitedHealth Group from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, March 2nd. One research analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $378.88.

UnitedHealth Group Stock Up 3.7%

UNH stock traded up $13.01 during midday trading on Tuesday, hitting $367.70. The stock had a trading volume of 7,126,226 shares, compared to its average volume of 9,633,842. The firm has a market cap of $333.95 billion, a price-to-earnings ratio of 27.77, a price-to-earnings-growth ratio of 1.53 and a beta of 0.40. The business has a 50-day moving average of $294.63 and a two-hundred day moving average of $316.54. UnitedHealth Group has a 52-week low of $234.60 and a 52-week high of $421.75. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. The company had revenue of $111.65 billion during the quarter, compared to analysts’ expectations of $109.84 billion. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. UnitedHealth Group’s revenue was up 2.0% on a year-over-year basis. During the same period last year, the company posted $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, equities research analysts forecast that UnitedHealth Group will post 18.29 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 800 shares of the firm’s stock in a transaction that occurred on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total value of $284,000.00. Following the transaction, the chief executive officer owned 17,805 shares of the company’s stock, valued at approximately $6,320,775. This trade represents a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.28% of the company’s stock.

Institutional Investors Weigh In On UnitedHealth Group

Hedge funds and other institutional investors have recently modified their holdings of the stock. Guerra Advisors Inc purchased a new stake in UnitedHealth Group during the 3rd quarter valued at approximately $1,059,000. Phoenix Financial Ltd. lifted its stake in UnitedHealth Group by 111.5% in the 3rd quarter. Phoenix Financial Ltd. now owns 41,986 shares of the healthcare conglomerate’s stock worth $14,282,000 after purchasing an additional 22,137 shares in the last quarter. Money Concepts Capital Corp lifted its stake in UnitedHealth Group by 59.1% in the 3rd quarter. Money Concepts Capital Corp now owns 12,380 shares of the healthcare conglomerate’s stock worth $4,275,000 after purchasing an additional 4,600 shares in the last quarter. Compass Wealth Management LLC purchased a new stake in UnitedHealth Group in the 3rd quarter worth $13,691,000. Finally, Public Sector Pension Investment Board lifted its stake in UnitedHealth Group by 43.1% in the 3rd quarter. Public Sector Pension Investment Board now owns 287,132 shares of the healthcare conglomerate’s stock worth $99,147,000 after purchasing an additional 86,432 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UNH reported Q1 revenue and adjusted EPS above Street estimates, cited margin improvement and Medicare Advantage tailwinds, and management set a higher FY outlook — the core catalyst for today’s positive sentiment. Read More.
• Positive Sentiment: Goldman Sachs raised its target on UNH and highlighted sector ETFs (like IHF) as ways to access UnitedHealth while managing Medicaid exposure, supporting analyst-driven buying flows. Read More.
• Positive Sentiment: Erste Group upgraded UNH from Hold to Buy, adding another sell?side endorsement that can bolster demand from institutional and retail investors. Read More.
• Positive Sentiment: High?profile media support: Jim Cramer and other commentators have highlighted health care (including UNH) as a stabilizing play versus AI?heavy names, which can attract retail flows. Read More.
• Positive Sentiment: Independent analysis points to a durable renewal cadence and Medicare Advantage payment tailwinds that underpin multi?year margin recovery — a fundamental positive for investors focused on earnings durability. Read More.
• Neutral Sentiment: Sector/ETF context — coverage on the iShares U.S. Healthcare Providers ETF (IHF) reminds investors there are low?volatility, diversified ways to play UNH exposure; helpful for flows but not specific to company fundamentals. Read More.
• Neutral Sentiment: Sector peer earnings: Centene and UHS reported better-than-expected results — positive for sector sentiment but mixed implications for UNH given different Medicaid/Medicare exposures. Read More. · Read More.
• Negative Sentiment: Insider selling — CEO Patrick Conway sold 800 shares at about $355 on April 23 (Form 4 filed). Size is modest, but insider sales can be viewed negatively by some market participants. Read More.
• Negative Sentiment: Some analysts and writeups warn that the stock has rallied fast and faces valuation and regulatory risk, leading to mixed target revisions and potential near?term volatility. Read More. · Read More.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.